← All companies

BDRX

Biodexa Pharmaceuticals Plc

BDRX Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.42

+0.10 +7.58%

Key statistics

from XBRL data in SEC filings

Market cap

$321B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$1.02 – $59.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 29, 2026 6-K Jul 9, 2026 6-K/A AMENDMENT NO. 1 Jul 1, 2026 6-K FORM 6-K Jun 30, 2026 6-K Jun 30, 2026 6-K Jun 17, 2026 6-K May 14, 2026 20-F Mar 27, 2026 6-K FORM 6-K Mar 27, 2026 6-K Mar 18, 2026 6-K Feb 4, 2026 6-K Jan 6, 2026 6-K FORM 6-K Jan 5, 2026 6-K Dec 18, 2025 6-K Nov 3, 2025 6-K Sep 12, 2025 6-K FORM 6-K Aug 18, 2025 6-K FORM 6-K Jul 31, 2025 6-K Jul 15, 2025 6-K Jun 27, 2025 6-K Jun 13, 2025 6-K FORM 6-K Jun 11, 2025 6-K FORM 6-K Jun 4, 2025 6-K FORM 6-K May 30, 2025 6-K May 23, 2025 6-K May 22, 2025 6-K FORM 6-K May 22, 2025 6-K May 15, 2025 6-K FORM 6-K May 12, 2025 6-K May 2, 2025 6-K FORM 6-K Apr 17, 2025 20-F Apr 11, 2025 6-K Apr 11, 2025 6-K FORM 6-K Mar 10, 2025 6-K FORM 6-K Mar 6, 2025 6-K FORM 6-K Feb 24, 2025 6-K FORM 6-K Feb 13, 2025 6-K FORM 6-K Feb 10, 2025 6-K FORM 6-K Jan 22, 2025 6-K Jan 17, 2025